APA (7th ed.) Citation

G, T., G, L., GD, K., L, L., F, R., A, S., . . . S, D. F. (2025). Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels. International journal of molecular sciences, 26(3), . https://doi.org/10.3390/ijms26031394

Chicago Style (17th ed.) Citation

G, Trovini, et al. "Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels." International Journal of Molecular Sciences 26, no. 3 (2025). https://doi.org/10.3390/ijms26031394.

MLA (9th ed.) Citation

G, Trovini, et al. "Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels." International Journal of Molecular Sciences, vol. 26, no. 3, 2025, https://doi.org/10.3390/ijms26031394.